Archives by Month:

Archives by Year:

S&P 500 Hits Goldman Sachs Year-End 2,050 Target

S&P 500 Hits Goldman Sachs Year-End 2,050 Target

It’s been quite a year for David Kostin and his flip-flopping Goldman equity strategy team. From a modest 1,900 year-end target in January (reached in May) to warning stocks are 30-45% overvalued in January to projecting the S&P 500 will reach 2,050 by year-end in July…Mission Accomplished today, 6 weeks early. Now what? Mission Accomplished… warning stocks are 30-45% overvalued in […]
Credit Suisse Analyst Michael Slifirski: New Non-Chinese Graphite And Vanadium Supply Could Create New Demand

Credit Suisse Analyst Michael Slifirski: New Non-Chinese Graphite And Vanadium Supply Could Create New Demand

More may really be better for end users and mining companies when it comes to graphite. Credit Suisse Analyst Michael Slifirski sees something a lot bigger than a zero-sum game in minerals. In this interview with The Mining Report, he explains how a steady source of graphite and vanadium from outside China could create whole new markets […]
TJX Companies Posts In-Line Q3 Earnings, Tightens FY View

TJX Companies Posts In-Line Q3 Earnings, Tightens FY View

The TJX Companies, Inc. (TJX – Analyst Report) reported earnings of 85 cents per share in the third quarter of fiscal 2015, in line with the Zacks Consensus Estimate. Earnings were ahead of the year-ago results by 13% backed by higher consumer traffic, improved margins and solid comparable-store sales growth in the consecutive months.   The Tjx Companies […]
E
                                                
                        Stock Market Party Over: Who’s Driving Home?

E Stock Market Party Over: Who’s Driving Home?

The DOW is up 25 straight days in a row. The DOW party has now moved from the apartment to the rooftop. The party is ending it’s 3:00am and the investors that are buying now are drunk on the ledges and an accident is just waiting to happen. This is the opportunity to be a […]
CytRx Announces Partial Clinical Hold On Main Drug – Big Buying Opportunity For Investors

CytRx Announces Partial Clinical Hold On Main Drug – Big Buying Opportunity For Investors

Shares of CytRx Corporation (CYTR) fell as low as 10% on the day as the company received notice that the FDA would place a partial clinical hold on its Aldoxorubicin drug, which is being used in patients with multiple types of cancer. This type of news has brought the share price down for CytRx today, but it […]
JDST Tankage

JDST Tankage

In other news, gold stock bulls to bears… ‘how you like me now sukkah?’ Of course, the bounce was highly readable in something approximating real time.  Anyone who did not take JDST profits has now imploded.  These 3X joyrides go both ways. Separately, we are managing the bounce quite nicely. I sold GDXJ a little while […]
A Yield Play Without Any Yield?

A Yield Play Without Any Yield?

On Friday a recently launched IPO fell about 15% on an earnings report that was poorly received by markets leaving the stock down 39% since its first day of trading in June. Naming names becomes difficult for compliance reasons but as a hint it is an infrastructure name and you would probably need to read […]
Stock Valuations Outrunning Profits Growth – And The Band Plays On

Stock Valuations Outrunning Profits Growth – And The Band Plays On

“We are still amazed by the chart [below], but it summarises the problem for those seeking to short stocks with fundamental weaknesses. In the last three years, the MSCI World Index has risen by 38% (11% per annum) whilst reported profits have risen by just 3% (that’s just 1% per annum!). As the events of […]
Gold Miners Rally Could Start With This Building Block

Gold Miners Rally Could Start With This Building Block

Click on picture to enlarge The building block to a decent rally in the hard hit miners complex could start with this taking place! The above chart reflects the Junior Miners ETF (GDXJ) to Senior miners ETF (GDX). When this ratio is heading south, GDJX is weaker than GDX. The ratio has been hit hard […]
Medtronic Posts In Line Earnings, Revenues Beat In Q2

Medtronic Posts In Line Earnings, Revenues Beat In Q2

Medtronic Inc.’s (MDT – Analyst Report) second-quarter fiscal 2015 adjusted earnings per share (EPS) came in at 96 cents, up 5.5% year over year, after adjusting for certain one-time items including a special charge related to an after-tax charitable cash donation made to the Medtronic Foundation and acquisition-related items primarily associated with the pending Covidien plc (COV – Analyst […]